Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Venetoclax and hypomethylating agents in FLT3-mutated acute myeloid leukemia.
Aldoss I, Zhang J, Mei M, Al Malki MM, Arslan S, Ngo D, Aribi A, Ali H, Sandhu K, Salhotra A, Koller P, Khaled S, Artz A, Snyder D, Nakamura R, Forman SJ, Stein AS, Marcucci G, Pullarkat V. Aldoss I, et al. Among authors: salhotra a. Am J Hematol. 2020 Oct;95(10):1193-1199. doi: 10.1002/ajh.25929. Epub 2020 Jul 28. Am J Hematol. 2020. PMID: 32628327 Free article.
Outcome of secondary acute myeloid leukemia treated with hypomethylating agent plus venetoclax (HMA-Ven) or liposomal daunorubicin-cytarabine (CPX-351).
Salhotra A, Aribi A, Ngo D, Zhang J, Sandhu K, Al-Malki M, Ali H, Koller P, Arslan S, Budde E, Khaled S, Dadwal S, Snyder DS, Artz A, Forman S, Nakamura R, Stein A, Marcucci G, Aldoss I, Pullarkat V. Salhotra A, et al. Am J Hematol. 2021 Jun 1;96(6):E196-E200. doi: 10.1002/ajh.26157. Epub 2021 Apr 8. Am J Hematol. 2021. PMID: 33719090 Free article. No abstract available.
Efficacy of blinatumomab for MRD relapse in ALL post allogenic HCT.
Ali H, Salhotra A, Stein AS, Nakamura R, Marcucci G, Forman SJ, Pullarkat V, Aldoss I. Ali H, et al. Among authors: salhotra a. Leuk Res. 2021 May;104:106579. doi: 10.1016/j.leukres.2021.106579. Epub 2021 Mar 30. Leuk Res. 2021. PMID: 33831656 No abstract available.
Use of high-dose mesna and hyperhydration leads to lower incidence of hemorrhagic cystitis after posttransplant cyclophosphamide-based allogeneic transplantation.
Mac S, Ngo D, Yang D, Chen J, Ali H, Arslan S, Dadwal S, Salhotra A, Cao T, Karras N, Aldoss I, Koller P, Artz A, Aribi A, Sandhu K, Pullarkat V, Stein A, Marcucci G, Forman SJ, Nakamura R, Al Malki MM. Mac S, et al. Among authors: salhotra a. Bone Marrow Transplant. 2021 Oct;56(10):2464-2470. doi: 10.1038/s41409-021-01364-0. Epub 2021 Jun 9. Bone Marrow Transplant. 2021. PMID: 34108676
Extramedullary disease relapse and progression after blinatumomab therapy for treatment of acute lymphoblastic leukemia.
Aldoss I, Otoukesh S, Zhang J, Mokhtari S, Ngo D, Mojtahedzadeh M, Al Malki MM, Salhotra A, Ali H, Aribi A, Sandhu KS, Arslan S, Koller P, Ball B, Stewart F, Curtin P, Artz A, Nakamura R, Marcucci G, Forman SJ, Stein AS, Pullarkat V. Aldoss I, et al. Among authors: salhotra a. Cancer. 2022 Feb 1;128(3):529-535. doi: 10.1002/cncr.33967. Epub 2021 Oct 11. Cancer. 2022. PMID: 34633671 Free article.
Tacrolimus initial steady state level in post-transplant cyclophosphamide-based GvHD prophylaxis regimens.
Yao JM, Yang D, Clark MC, Otoukesh S, Cao T, Ali H, Arslan S, Aldoss I, Artz A, Amanam I, Salhotra A, Pullarkat V, Sandhu K, Stein A, Marcucci G, Forman SJ, Nakamura R, Al Malki MM. Yao JM, et al. Among authors: salhotra a. Bone Marrow Transplant. 2022 Feb;57(2):232-242. doi: 10.1038/s41409-021-01528-y. Epub 2021 Nov 20. Bone Marrow Transplant. 2022. PMID: 34802049 Free PMC article.
Long-term follow-up of patients with poor-risk acute leukemia treated on a phase 2 trial undergoing intensified conditioning regimen prior to allogeneic hematopoietic cell transplantation.
Salhotra A, Yang D, Mokhtari S, Hui S, Al Malki MM, Armenian S, Sigala B, Aldoss I, Pullarkat V, Forman S, Marcucci G, Nakamura R, Artz A, Wong J, Stein A. Salhotra A, et al. Leuk Lymphoma. 2022 May;63(5):1220-1226. doi: 10.1080/10428194.2021.2012661. Epub 2021 Dec 9. Leuk Lymphoma. 2022. PMID: 34879769 Clinical Trial.
136 results